MIDWEST HOLDING INC (MDWT)

US59833J2069 - Common Stock

26.99  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MDWT. MDWT was compared to 141 industry peers in the Insurance industry. Both the profitability and financial health of MDWT have multiple concerns. MDWT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!



1

1. Profitability

1.1 Basic Checks

MDWT had negative earnings in the past year.
In the past year MDWT had a positive cash flow from operations.
MDWT had negative earnings in 4 of the past 5 years.
MDWT had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

MDWT has a worse Return On Assets (-0.10%) than 72.22% of its industry peers.
MDWT has a worse Return On Equity (-17.23%) than 81.94% of its industry peers.
MDWT has a Return On Invested Capital of 0.23%. This is comparable to the rest of the industry: MDWT outperforms 42.36% of its industry peers.
Industry RankSector Rank
ROA -0.1%
ROE -17.23%
ROIC 0.23%
ROA(3y)-0.9%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MDWT's Operating Margin of 7.60% is in line compared to the rest of the industry. MDWT outperforms 48.61% of its industry peers.
MDWT does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 7.6%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

MDWT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MDWT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for MDWT has been increased compared to 5 years ago.
Compared to 1 year ago, MDWT has a worse debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of MDWT is 0.25, which is an excellent value as it means it would take MDWT, only 0.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.25, MDWT belongs to the best of the industry, outperforming 95.14% of the companies in the same industry.
MDWT has a Debt/Equity ratio of 1.82. This is a high value indicating a heavy dependency on external financing.
MDWT has a Debt to Equity ratio of 1.82. This is amonst the worse of the industry: MDWT underperforms 90.28% of its industry peers.
Even though the debt/equity ratio score it not favorable for MDWT, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 0.25
Altman-Z N/A
ROIC/WACC0.03
WACC7.98%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

7

3. Growth

3.1 Past

MDWT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.32%, which is quite impressive.
The Revenue has grown by 378.45% in the past year. This is a very strong growth!
Measured over the past years, MDWT shows a very strong growth in Revenue. The Revenue has been growing by 67.60% on average per year.
EPS 1Y (TTM)57.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)378.45%
Revenue growth 3Y274.72%
Revenue growth 5Y67.6%
Sales Q2Q%1733.93%

3.2 Future

MDWT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 208.68% yearly.
The Revenue is expected to grow by 34.73% on average over the next years. This is a very strong growth
EPS Next Y828.57%
EPS Next 2Y208.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year73.04%
Revenue Next 2Y34.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

MDWT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 8.54, which indicates a very decent valuation of MDWT.
Based on the Price/Forward Earnings ratio, MDWT is valued a bit cheaper than the industry average as 67.36% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.73. MDWT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.54

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MDWT is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.01
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDWT's earnings are expected to grow with 208.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y208.68%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MDWT!.
Industry RankSector Rank
Dividend Yield N/A

MIDWEST HOLDING INC

NASDAQ:MDWT (12/20/2023, 8:23:45 PM)

26.99

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)03-25 2024-03-25/amc
Inst Owners1%
Inst Owner Change0%
Ins Owners8033.91%
Ins Owner Change0%
Market Cap100.94M
Analysts45.71
Price Target27.54 (2.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1485.07%
Min EPS beat(2)-430.5%
Max EPS beat(2)3400.65%
EPS beat(4)2
Avg EPS beat(4)671.12%
Min EPS beat(4)-430.5%
Max EPS beat(4)3400.65%
EPS beat(8)4
Avg EPS beat(8)362.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)95.87%
Min Revenue beat(2)62.12%
Max Revenue beat(2)129.61%
Revenue beat(4)3
Avg Revenue beat(4)44.19%
Min Revenue beat(4)-56.58%
Max Revenue beat(4)129.61%
Revenue beat(8)4
Avg Revenue beat(8)-9.97%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-12.41%
EPS NY rev (3m)-12.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)99900%
Revenue NY rev (1m)13.87%
Revenue NY rev (3m)13.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.54
P/S 1.13
P/FCF 1.01
P/OCF 1.01
P/B 7.37
P/tB 7.37
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)3.16
Fwd EY11.72%
FCF(TTM)26.64
FCFY98.7%
OCF(TTM)26.74
OCFY99.07%
SpS23.92
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -17.23%
ROCE 0.29%
ROIC 0.23%
ROICexc 0.25%
ROICexgc 0.26%
OM 7.6%
PM (TTM) N/A
GM N/A
FCFM 111.36%
ROA(3y)-0.9%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 0.25
Debt/EBITDA N/A
Cap/Depr -1.51%
Cap/Sales 0.41%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.98%
ROIC/WACC0.03
Cap/Depr(3y)4.44%
Cap/Depr(5y)20.66%
Cap/Sales(3y)3.18%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y828.57%
EPS Next 2Y208.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)378.45%
Revenue growth 3Y274.72%
Revenue growth 5Y67.6%
Sales Q2Q%1733.93%
Revenue Next Year73.04%
Revenue Next 2Y34.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y216.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y462.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y464.3%
OCF growth 3YN/A
OCF growth 5YN/A